Physicochemical Properties and Thermal Stability of Quercetin Hydrates in The Solid State
Physicochemical Properties and Thermal Stability of Quercetin Hydrates in The Solid State
net/publication/256906962
CITATIONS READS
20 231
6 authors, including:
Some of the authors of this publication are also working on these related projects:
Estudio del estado sólido de fármacos escasamente solubles en agua y su impacto sobre la equivalencia in vitro View project
All content following this page was uploaded by Alejandro Pedro Ayala on 22 April 2019.
Thermochimica Acta
journal homepage: www.elsevier.com/locate/tca
a r t i c l e i n f o a b s t r a c t
Article history: In the present work three samples of quercetin raw materials (QCTa, QCTb and QCTc), purchased from
Received 21 December 2011 different Brazilian suppliers, were characterized employing scanning electron microscopy, Raman spec-
Received in revised form 10 April 2012 troscopy, simultaneous thermogravimetry and infrared spectroscopy, differential scanning calorimetry,
Accepted 13 April 2012
and variable temperature-powder X-ray diffraction, in order to know their physicochemical properties,
Available online 21 April 2012
specially the thermal stability in solid state. The results demonstrated that the raw materials of quercetin
analyzed present distinct crystalline structures, ascribed to the different degree of hydration of their crys-
Keywords:
tal lattice. The thermal stability of these quercetin raw materials in the solid state was highly dependent
Hydrates
Physicochemical properties
on their degree of hydration, where QCTa (quercetin dihydrate) was thermodynamically more stable than
Quercetin the other two samples.
Solid state © 2012 Elsevier B.V. All rights reserved.
Thermal stability
0040-6031/$ – see front matter © 2012 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.tca.2012.04.015
Author's personal copy
2. Experimental
3.1. Scanning electron microscopy
2.1. Materials
The photomicrographs revealed by SEM (Fig. 2) show that the
Three samples of pharmaceutical grade quercetin (QCT) were particle size order of quercetin samples is QCTb > QCTa > QCTc.
analyzed as supplied, without purification or recrystallization. These results can explain, at least partially, the lower solubility in
QCTa, QCTb and QCTc were purchased from Deg (São Paulo, Brazil), water, at 37 ◦ C, of QCTb (2.6 g mL−1 ) when compared with the
Galena (São Paulo, Brazil) and SPFarma (São Paulo, Brazil), respec- other samples (3.7 g mL−1 for QCTa and 6.5 g mL−1 for QCTc)
tively. [13]. However, it is difficult to determine if these differences in
the particle size and morphology are caused by the pseudopoly-
2.2. Scanning electron microscopy (SEM) morphism or by changes in the crystal growth conditions, such
as degree of supersaturation, nature of the crystallization solvent,
The photomicrographs were taken at a voltage of 10 kV and a speed of solution agitation, rate of cooling, or presence of impurities
magnification of 3000× using a Jeol JSM 6060 microscope (Tokyo, [10].
Japan). The samples were fixed on brass stubs using a double-sided
adhesive tape and vacuum-coated with a thin layer of gold. 3.2. Fourier transform–Raman spectroscopy
2.3. Fourier transform–Raman spectroscopy The Raman spectra obtained for the three samples of quercetin
in the fingerprint region are presented in Fig. 3. It is possible to
The Raman spectra of the samples were recorded using a Bruker associate the spectrum obtained for QCTa with that previously
Vertex 70 FTIR/FT-Raman spectrometer (Ettlingen, Germany) reported by Cornard et al. [14] and Teslova et al. [15]. Its main
equipped with a Nd:YAG laser (1064 nm excitation line) and a features are (C O) stretching (1660 cm−1 ), (C2 C3) stretching
liquid-nitrogen cooled Ge detector. The analyses were performed at (1608 cm−1 ), and phenyl and benzo rings (C C) stretchings (1590
room temperature, by accumulating 1024 scans over the frequency and 1549 cm−1 ). The group of bands between 1500 and 1300 cm−1
range from 2000 up to 100 cm−1 , and with a resolution of 4 cm−1 . cannot be described by a single internal coordinate, but it can be
associated with a set of mechanical coupled vibrations of (C C)
2.4. Differential scanning calorimetry (DSC) and stretchings and in-plane ␦(CH) and ␦(C OH) bendings. Although it
thermogravimetry (TG) is not possible to associate a single band to the (C2 C1 ) stretching,
contributions of interring bond are expected in this region.
Simultaneous DSC and TG experiments were performed using As it will be shown later by VTPXRD, QCTb seems to be a mix-
a Netzsch STA 409 PC/PG equipment (Selb, Germany) coupled to ture of different crystalline forms of the flavonoid. Thus, we will
a Bruker Tensor 27 Fourier Transformed infrared spectrometer focus our discussion in the comparison between QCTa and QCTc.
(Ettlingen, Germany). The analyses were performed from room The most remarkable differences observed in the Raman spectra of
temperature (20 ◦ C) up to 500 ◦ C, at 10 ◦ C min−1 , under nitrogen gas these samples are the shift of the (C2 C3) stretching mode from
flow (60 mL min−1 ), by using crimped aluminum pans with a pin- 1608 cm−1 to 1616 cm−1 and the shift of the bands around 1439
hole in which approximately 5 mg of the samples were accurately and 1328 cm−1 , which are related to the (C2 C1 ) stretching. A
weighed. similar effect was observed by Cornard et al. [16] when the Raman
lines of quercetin in the solid state and in solution were compared.
2.5. Variable temperature-powder X-ray diffraction (VTPXRD) The frequency variations observed can be ascribed to changes in
the molecular conformation induced by the crystal field and that
The diffractograms of the samples were recorded using a Rigaku are specially related to the relative orientation of the phenyl and
Rint 2000 equipment (Tokyo, Japan) under the following operating pyrone rings, showing that the conformational changes are mostly
conditions: Cu K␣ radiation ( = 1.5406 Å), reflection mode, voltage located around the C2 C1 bond. Quantum mechanical calculations
of 40 kV, current of 40 mA, scanning rate of 0.5◦ 2 min−1 , scanning lead to a nonplanar structure with a torsion angle of about 28◦ [16],
Author's personal copy
Fig. 4. Differential scanning calorimetry curves of quercetin samples (QCTa, QCTb and QCTc). The insets show a magnified region for better visualization.
Fig. 5. Thermogravimetry curves of quercetin samples (QCTa, QCTb and QCTc). The insets show the integrated intensity of characteristic bands of H2 O and CO2 observed in
the infrared spectra of the released gases.
Table 1
Main diffraction peaks obtained for quercetin samples (QCT) and their new crystalline forms by using variable temperature-powder X-ray diffraction ( = 1.5406 Å).
QCTa 10.65; 12.34; 13.51; 14.07; 15.76; 7.47; 9.17; 10.77; 12.66; 14.36; 15.01; –
24.29; 26.52; 27.27; 29.54 16.71; 21.15; 25.86
QCTb 10.70; 12.34; 13.48; 14.02; 17.83; 11.79; 12.11; 12.44; 13.36; 13.75; 7.47; 9.24; 10.77; 12.94; 14.36; 15.01;
24.26; 26.41; 27.34; 28.20; 29.5 16.73; 17.77; 26.19; 28.04 16.71; 21.90; 25.92
QCTc 4.52; 8.86; 9.69; 13.00; 16.58; 21.86; 9.89; 10.72; 13.24; 17.71; 21.66; 24.31; 7.50; 9.30; 10.83; 13.03; 14.45; 15.21;
24.76; 25.94; 27.86 25.95; 27.57 16.71; 21.80; 25.86
a
Phase transition 1 occurred at 110 ◦ C for QCTa and QCTb and at 40 ◦ C for QCTc.
b
Phase transition 2 occurred at 270 ◦ C for QCTb and 250 ◦ C for QCTc.
Author's personal copy
Fig. 6. Variable temperature-powder X-ray diffraction patterns of quercetin samples: (a) QCTa, (b) QCTb, and (c) QCTc.
presented by QCTa and QCTb and, thus, this sample seems to cor- corresponding anhydrous forms was different from that observed
respond to a third crystalline form of quercetin. for the original forms and different from each other (Table 1). In
After the characterization of their crystalline structures, the the same way, a second phase transition was observed for QCTb
thermal stability of the three quercetin hydrates was analyzed in (at 270 ◦ C) and QCTc (at 250 ◦ C), confirming the occurrence of a
the solid state by VTPXRD. The phase transition expected because of solid–solid transition of the corresponding anhydrous forms and
the molecular rearrangement during the dehydration of quercetin the above-mentioned thermal behavior by both samples. On the
was observed at 110 ◦ C for QCTa (Fig. 6a) and QCTb (Fig. 6b), and other hand, no phase transition was observed for QCTa on heat-
40 ◦ C for QCTc (Fig. 6c). The diffraction pattern obtained for the ing above 110 ◦ C. The resulting diffraction patterns at 270 ◦ C are
Fig. 7. Powder X-ray diffraction patterns of quercetin samples (QCTa, QCTb and QCTc) at (a) room temperature and (b) 270 ◦ C.
Author's personal copy
compared in Fig. 7b. QCTb and QCTc exhibited peaks in the same [3] G.S. Borghetti, I.S. Lula, R.D. Sinisterra, V.L. Bassani, Quercetin/-cyclodextrin
positions, which suggests that the new crystalline forms are the solid complexes prepared in aqueous solution followed by spray-drying or by
physical mixture, AAPS PharmSciTech 10 (2009) 235–242.
same. This new crystalline form presented some peaks at a diffrac- [4] G.G.Z. Zhang, D. Law, E.A. Schmitt, Y. Qiu, Phase transformation considerations
tion angle coincident to that exhibited by the anhydrous form of during process development and manufacture of solid oral dosage forms, Adv.
QCTa. Unfortunately, the diffraction pattern of the three quercetin Drug Deliv. Rev. 56 (2004) 371–390.
[5] S.C. Bischoff, Quercetin: potentials in the prevention and therapy of disease,
samples could not be monitored at temperatures above 270 ◦ C, in Curr. Opin. Clin. Nutr. Metab. Care 11 (2008) 733–740.
which the flavonoid begins melting. [6] G.S. Borghetti, I.M. Costa, P.R. Petrovick, V.P. Pereira, V.L. Bassani, Char-
Taking together, the thermal stability in the solid state of acterization of different samples of quercetin in solid-state: indication of
polymorphism occurrence, Pharmazie 61 (2006) 802–804.
quercetin raw materials evaluated in the present study was highly
[7] S. Olejniczak, M.J. Potrzebowski, Solid state NMR studies and density functional
dependent on their degree of hydration, where QCTa (quercetin theory (DFT) calculations of conformers of quercetin, Org. Biomol. Chem. 2
dihydrate) was thermodynamically more stable than QCTb and (2004) 2315–2322.
[8] A.W. Boots, G.R.M.M. Haenen, A. Bast, Health effects of quercetin: from antiox-
QCTc samples. The hydration water molecules of QCTa are probably
idant to nutraceutical, Eur. J. Pharmacol. 585 (2008) 325–337.
involved in stronger intermolecular hydrogen bonds that con- [9] S.R. Vippagunta, H.G. Brittain, D.J.W. Grant, Crystalline solids, Adv. Drug Deliv.
tribute to the coherence of its crystalline structure, resulting in a Rev. 48 (2001) 3–26.
lower energy state. Based upon its minimal potential for transition, [10] B. Rodríguez-Spong, C.P. Price, A. Jayasankar, A.J. Matzger, N. Rodríguez-
Hornedo, General principles of pharmaceutical solid polymorphism: a
quercetin dihydrate seems to be the most appropriate crystalline supramolecular perspective, Adv. Drug Deliv. Rev. 56 (2004) 241–274.
form for the development of solid dosage forms. However, a [11] A.P. Ayala, Polymorphism in drugs investigated by low wavenumber Raman
less stable crystalline form can be necessary in view to improve scattering, Vib. Spectrosc. 45 (2007) 112–116.
[12] A.P. Ayala, H.W. Siesler, S.M.S.V. Wardell, N. Boechat, V. Dabbene, S.L. Cuffini,
the aqueous solubility and the bioavailability of the flavonoid Vibrational spectra and quantum mechanical calculations of antiretroviral
[1]. Therefore, the knowledge of the experimental/environmental drugs: nevirapine, J. Mol. Struct. 828 (2007) 201–210.
conditions under which phase transitions occur is an essential pre- [13] M. Petry, G.S. Borghetti, V.L. Bassani, Influência de ciclodextrinas e polímero
hidrofílico sobre a hidrossolubilidade de diferentes formas polimórficas de
formulation step to assure the quality of the final product, including quercetina, Lat. Am. J. Pharm. 26 (2007) 831–836.
nutraceutics, cosmetics or pharmaceutics. [14] J.P. Cornard, L. Dangleterre, C. Lapouge, Computational and spectroscopic char-
acterization of the molecular and electronic structure of the Pb(II)–quercetin
complex, J. Phys. Chem. A 109 (2005) 10044–10051.
4. Conclusions [15] T. Teslova, C. Corredor, R. Livingstone, T. Spataru, R.L. Birke, J.R. Lombardi, M.V.
Canamares, M. Leona, Raman and surface-enhanced Raman spectra of flavone
The present work was able to demonstrate that the three raw and several hydroxyl derivatives, J. Raman Spectrosc. 38 (2007) 802–818.
[16] J.P. Cornard, J.C. Merlin, A.C. Boudet, L. Vrielynck, Structural study of quercetin
materials of quercetin analyzed, purchased from different Brazilian
by vibrational and electronic spectroscopies combined with semiempirical cal-
suppliers, present distinct crystalline structures due to the differ- culations, Biospectroscopy 3 (1997) 183–193.
ent degree of hydration of their crystal lattice. However, the more [17] M. Rossi, L.F. Rickles, W.A. Halpin, The crystal and molecular structure of
quercetin: a biologically active and naturally occurring flavonoid, Bioorg. Chem.
relevant finding is that the thermal stability of quercetin in the solid
14 (1986) 55–69.
state is highly dependent on its degree of hydration. This character- [18] G.-Z. Jin, Y. Yamagata, K. Tomita, Structure of quercetin dehydrate, Acta Crys-
istic is an important information for the processing control in the tallogr. Sect. C 46 (1990) 310–313.
manufacturing of nutraceutics, cosmetics or pharmaceutics, since [19] J. Zhou, L.-F. Wang, J.-Y. Wang, N. Tang, Synthesis, characterization, antioxida-
tive and antitumor activities of solid quercetin rare earth (III) complexes, J.
phase transitions resulting from heating may lead to changes in Inorg. Biochem. 83 (2001) 41–48.
the physicochemical properties of the flavonoid and, thus, in its [20] E.M. da Costa, J.M. Barbosa Filho, T.G. do Nascimento, R.O. Macêdo, Ther-
bioavailability. mal characterization of the quercetin and rutin flavonoids, Thermochim. Acta
392–393 (2002) 79–84.
[21] J.L. Koontz, J.E. Marcy, S.F. O’keefe, S.E. Duncan, Cyclodextrin inclusion com-
Role of the funding source plex formation and solid-state characterization of the natural antioxidants
␣-tocopherol and quercetin, J. Agric. Food Chem. 57 (2009) 1162–1171.
[22] Y. Zheng, A.H.L. Chow, Production and characterization of a spray-dried
The authors are grateful to Coordenação de Aperfeiçoamento de hydroxypropyl--cyclodextrin/quercetin complex, Drug Dev. Ind. Pharm. 35
Pessoal de Nível Superior (CAPES), Conselho Nacional de Desen- (2009) 727–734.
volvimento Científico e Tecnológico (CNPq), Fundação Cearense de [23] T. Pralhad, K. Rajendrakumar, Study of freeze-dried quercetin–cyclodextrin
binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis, J. Pharm.
Apoio ao Desenvolvimento Científico e Tecnológico (FUNCAP), and Biomed. Anal. 34 (2004) 333–339.
to Instituto de Pesquisa, Desenvolvimento e Inovação (IPDI) for the [24] R. Kale, M. Saraf, A. Juvekar, P. Tayade, Decreased B16F10 melanoma growth and
financial support for the conduct of the research and scholarships. impaired tumour vascularization in BDF1 mice with quercetin–cyclodextrin
binary system, J. Pharm. Pharmacol. 58 (2006) 1351–1358.
[25] K.V. Sri, A. Kondaiah, J.V. Ratna, A. Annapurna, Preparation and characterization
References of quercetin and rutin cyclodextrin inclusion complexes, Drug Dev. Ind. Pharm.
33 (2007) 245–253.
[1] A.S. Raw, M.S. Furness, D.S. Gill, R.C. Adams, F.O. Holcombe Jr., L.X. Yu, Regula- [26] T.-H. Wu, F.-L. Yen, L.-T. Lin, T.-R. Tsai, C.-C. Lin, T.-M. Cham, Preparation, physic-
tory considerations of pharmaceutical solid polymorphism in abbreviated new ochemical characterization, and antioxidant effects of quercetin nanoparticles,
drug applications (ANDAs), Adv. Drug Deliv. Rev. 56 (2004) 397–414. Int. J. Pharm. 346 (2008) 160–168.
[2] J. Sheng, G.M. Venkatesh, S.P. Duddu, D.J.W. Grant, Dehydration behavior of [27] S. Scalia, M. Mezzena, Incorporation of quercetin in lipid microparticles: effect
eprosartan mesylate dehydrate, J. Pharm. Sci. 88 (1999) 1021–1029. on photo- and chemical-stability, J. Pharm. Biomed. Anal. 49 (2009) 90–94.